Opdivo (nivolumab)

pCPA File Number: 22337
Negotiation Status:
Concluded with an LOI
Indication(s):
For the neoadjuvant treatment of adult patients with resectable NSCLC (tumours ≥4cm or node positive) when used in combination with platinum-doublet chemotherapy
Sponsor/Manufacturer:
BRISTOL-MYERS SQUIBB CANADA
CADTH Project Number:
PC0303
pCPA Engagement Letter Issued:
Negotiation Process Concluded: